Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium

• Published in: Gut microbes Vol. 14; no. 1; p. 2078619
• Main Authors: Si, Jiyeon, Kang, Hyena, You, Hyun Ju, Ko, GwangPyo
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 31.12.2022; Taylor & Francis Group
• Subjects: Akkermansia; Akkermansia muciniphila; biotherapeutics; effective compounds; Gastrointestinal Microbiome; Humans; Insulin Resistance; metabolic inflammation; molecular mechanisms; Review; Verrucomicrobia - metabolism; biotherapeutics; molecular mechanisms; Akkermansia muciniphila; metabolic inflammation; effective compounds

Despite a short history since its first isolation, Akkermansia muciniphila has been extensively studied in relation to its effects on human metabolism. A recent human intervention study also demonstrated that the bacterium is safe to use for therapeutic purposes. The best-known effects of A. mucinip...